Építés alatt – nem éles oldal
Belépés

What researchers published on Petefészekrák

43 193 papers, newest first.

Showing 180 of 43 193

  • EsetismertetésFamilial Ovarian Teratoma With Neural Tissue Expression and Anti-NMDAR Encephalitis.Neurology(R) neuroimmunology & neuroinflammation
  • Matrix Softness and Fluid Shear Force Act Through TRPV4 to Promote Ovarian Cancer Stemness.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
  • ÁttekintésTumo​r-associated macrophages in ovarian, prostate, thyroid and pancreatic neuroendocrine tumors: molecular crosstalk and therapeutic perspectives.Molecular biology reports
  • Generation of mixed ovarian cancer and fibroblast spheroids by bioprinting.In vitro models
  • Cross-database thromboembolic reporting signals for ovarian cancer therapies: a focus on bevacizumab.BMC cancer
  • [Emphasis on the standardization of initial treatment for ovarian cancer].Zhonghua yi xue za zhi
  • ÁttekintésAdvances in Biomarker Discovery for Early Ovarian Cancer Diagnosis.Cells
  • Diagnostic Performance of Contrast-Enhanced Computed Tomography in Predicting Lymph Node Metastasis in Epithelial Ovarian Cancer: The Added Value of Combining CT with CA-125.Diagnostics (Basel, Switzerland)
  • Infrared Treatment Alters the Chemical Profile and In Vitro Bioactivity of Jojoba Oil: Antimicrobial, Biofilm Formation Inhibition and Ovarian Cancer Cell Responses.International journal of molecular sciences
  • FABP4 is associated with ROS-dependent ferroptosis inhibition and platinum resistance in ovarian cancer.Tissue & cell
  • ÁttekintésImmune Resistance and Anti-Tumor Immunity in the Ovarian Tumor Microenvironment.Cells
  • PADI2 facilitates progression and cisplatin resistance of epithelial ovarian cancer via m6A methylation.iScience
  • Biologic and immunologic characteristics of ovarian cancers that are associated with p53 autoantibodies.Cancer
  • ÁttekintésPrognostic Value of the KELIM Score Versus Conventional CA-125 Kinetics in Ovarian Cancer: A Systematic Review and Meta-Analysis.Diagnostics (Basel, Switzerland)
  • Comparison of Sonidegib and Vismodegib Efficiency in Drug-Sensitive and Resistant Ovarian Cancer Cell Lines-2D and 3D Model Study.International journal of molecular sciences
  • ÁttekintésThe Role of D-3-Phosphoglycerate Dehydrogenase (PHGDH) in Chemoresistance in Ovarian Cancer: Molecular Insights and Therapeutic Potential.International journal of molecular sciences
  • Multicenter Evaluation of Decentralized Homologous Recombination Deficiency Testing for Enhanced Molecular Diagnosis of Ovarian Cancer.International journal of molecular sciences
  • A leakage-aware and interpretable machine learning framework for ovarian cancer prediction using the PLCO screening dataset.Frontiers in oncology
  • Hypoxia-Associated Glycolytic-Lipogenic Reprogramming and Impaired Antigen Presentation in SPP1+ Tumor-Associated Macrophages in Ovarian Cancer.International journal of molecular sciences
  • Correction: Gralewska-Zając et al. Liposomal Vitamin C as a Modulator of the Efficacy of Ceralasertib Therapy in Ovarian Cancer. Int. J. Mol. Sci. 2026, 27, 2630.International journal of molecular sciences
  • ÁttekintésFolate Receptor Alpha (FRα/FOLR1) in Cancer: Diagnostic, Prognostic or Predictive Biomarker? A Critical Review of Its Clinical Utility.International journal of molecular sciences
  • Comparison of Survival Outcomes with First-Line PARP Inhibitor Maintenance According to BRCA Mutation and Homologous Recombination Deficiency Status in Advanced Ovarian Cancer: A Single-Center Retrospective Cohort Study.Cancers
  • ÁttekintésExtracellular Vesicle-Associated Epithelial-Mesenchymal Plasticity (EMP) as a Driver of Metastatic Evolution and Therapeutic Resistance in Ovarian Cancer.Cancers
  • Platelet-Derived Extracellular Vesicles for the Diagnosis of Ovarian Cancer.Cancers
  • "Hearing the Ovarian Cancer Whisper": A Pipeline Program Introducing Medical Students to Gynecologic Oncology, Focusing on the Diagnosis and Management of Ovarian Cancer.Medical science educator
  • Minimally invasive surgery improves surgical and analgesic outcomes in overweight or obese patients with borderline ovarian tumors: A retrospective cohort study.Medicine
  • Compartment-Resolved Profiling Identifies Shared Stromal Programs and Clarifies Molecular Subtype Origins in Ovarian Cancer.Cancer research
  • ÁttekintésCellular senescence in ovarian cancer: context-dependent effects on tumor immunity and therapy response.Frontiers in immunology
  • Risk Factor Profiles May Differ Between Younger-Onset and Late-Onset Colorectal Cancer: An Exploratory Analysis of Individual and Cumulative Risk Factors Among the Prostate, Lung, Colorectal and Ovarian Cohort.Asia-Pacific journal of clinical oncology
  • Multi-omics-constrained kinetic models quantify pathway rewiring and predict metabolic vulnerabilities in BRCA1-deficient ovarian cancer.Cell systems
  • Clinical characteristics and treatment strategies of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis based on a case series.Frontiers in neurology
  • Tuberculous Salpingo-Oophoritis Mimicking Ovarian Malignancy: A Case Report of a Diagnostic Dilemma.Clinical case reports
  • MRPL47 as a mitochondrial biomarker for early detection and therapeutic response in ovarian cancer.Molecular therapy. Oncology
  • Surgical opportunities for primary prevention of high-grade serous ovarian cancer: a procedure-level analysis of opportunistic salpingectomy.Journal of ovarian research
  • Perillaldehyde (PAE) Regulates Ovarian Cancer by Modulating HSP70 and Regulating the PI3K/AKT Signaling Pathway.Archives of biochemistry and biophysics
  • Vizsgálati eredményPamiparib plus surufatinib with ctDNA monitoring in platinum-resistant ovarian cancer after PARP inhibitor progression: a phase Ib/II trial (POST-PARPi).BMC medicine
  • AIF promotes ovarian cancer progression by competitively binding TRAP1 to stabilize MtCK1 to drive phosphocreatine synthesis.Journal of translational medicine
  • Fertility-sparing surgery for early-stage epithelial ovarian cancer: evolving criteria for patient selection.Japanese journal of clinical oncology
  • Randomizált vizsgálatFuzuloparib in combination with apatinib versus fuzuloparib alone for recurrent ovarian cancer: a randomized, open-label, phase 2 trial.Journal of ovarian research
  • PD-L1 expression in epithelial ovarian cancer and survival: a retrospective cohort study.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
  • Racial and ethnic differences in ovarian cancer survival across SEER registry states.Gynecologic oncology
  • ÁttekintésThe hidden genome of high-grade serous ovarian carcinoma: repetitive DNA, extrachromosomal DNA, and complex structural variation.Frontiers in molecular biosciences
  • The p38α MAPK-MK2 axis drives chemotherapy-mediated nuclear actin remodeling to promote ovarian cancer progression.Proceedings of the National Academy of Sciences of the United States of America
  • Editorial: New horizons in the management of advanced epithelial ovarian cancer.Frontiers in medicine
  • Epigenetic Divergence Distinguishes Molecularly and Histologically Distinct Subtypes of Small Cell Carcinoma of the Ovary Hypercalcemic Type.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • Cell-death-associated inflammatory remodeling of the SPP1/KRT5 axis in high-grade serous ovarian cancer: multi-omics, single-cell, and irradiation validation.Frontiers in cell and developmental biology
  • A peritoneal cancer index above 14 is associated with incomplete cytoreduction in cytoreductive surgery with HIPEC for high-grade serous ovarian cancer.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • Deep learning radiomics nomogram based on enhanced CT for differentiating epithelial ovarian borderline tumors and early-stage epithelial ovarian cancers.BMC cancer
  • Causal effects of genetically predicted CCL25 signaling on ovarian cancer risk: A 2-sample Mendelian randomization study.Medicine
  • EsetismertetésManagement of an incidentally discovered pancreatic neoplasm mimicking an ovarian neoplasm during pregnancy: A case report.Medicine
  • MetaanalízisPoly (ADP-ribose) polymerase inhibitors (PARPi) for treating advanced epithelial ovarian cancer.The Cochrane database of systematic reviews
  • Hypermethylation in CpG-rich cfDNA fragments enables accurate detection of circulating tumor DNA in BRCA1- and BRCA2-associated breast and ovarian cancer.NPJ breast cancer
  • Selective miRNA network modulation by quinolone derivative CF5 is associated with potent anti-ovarian cancer activity.Bioscience reports
  • ÁttekintésBEHOLD phase 3 clinical development program of mocertatug rezetecan in ovarian and endometrial cancer.Gynecologic oncology
  • [Oncogenetics consultation].Annales de chirurgie plastique et esthetique
  • Considerations on external validation, potential data leakage, and model selection in a PET/CT-based radiomics model predicting residual disease in ovarian cancer.Journal of ovarian research
  • Risovalisib for PIK3CA-mutated recurrent or persistent ovarian clear cell carcinoma: a single-arm, multicentre, phase 2 trial.The Lancet. Oncology
  • Identification and Biological Evaluation of Fisetin as a Novel DYRK1B Inhibitor in Ovarian Cancer with Apoptotic and Ferroptotic Effects.Drug design, development and therapy
  • Prospective Analysis of Breastfeeding History and Ovarian Cancer Risk: Results From the Ovarian Cancer Cohort Consortium.International journal of cancer
  • EsetismertetésBreast metastasis from BRCA1-mutated ovarian cancer: response to parp inhibition and a potential lymphatic route.BMC women's health
  • ÁttekintésAdvances in the application of fluorescent probes for ovarian cancer.Journal of ovarian research
  • Blood-based RNA biomarker for the early detection of ovarian cancer.Nature medicine
  • Correction: Carboxylesterase 1 is a core metabolic vulnerability of platinum-resistant high-grade serous ovarian carcinoma.Journal of experimental & clinical cancer research : CR
  • A novel candidate biomarker for detecting premalignant and early ovarian cancer.Nature medicine
  • ÁttekintésExosomal microRNAs in apoptosis and chemoresistance of ovarian cancer: mechanisms and therapeutic implications.Medical oncology (Northwood, London, England)
  • Development and Validation of Machine Learning Models Incorporating TGFBIp Expression for Prognosis Prediction in Epithelial Ovarian Cancer.Cancer reports (Hoboken, N.J.)
  • Synergistic antitumor activity of Napabucasin and Curcumin via ROS accumulation and apoptotic cell death induction in ovarian cancer cells.Molecular biology reports
  • Association of Preoperative Systemic Inflammation Response Index and Neutrophil-to-Lymphocyte Ratio with Cytoreduction Outcomes in Ovarian Cancer: A Retrospective Cohort Study.International journal of women's health
  • RAD52 is a therapeutic vulnerability for acquired PARP inhibitor resistance in ovarian cancer.JCI insight
  • EsetismertetésManagement of a perforated extensive ovarian tumor with radical resection and long-term tumor-free outcome: a case report.Journal of medical case reports
  • Feasibility of transvaginal ultrasound with endorectal micro-enema for the detection of rectosigmoid anastomotic leakage after cytoreductive surgery for ovarian cancer: preliminary experience from an ambispective single-center study.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • UHRF1 Supports PARP1 Protein Stability and Ovarian Cancer Progression by Limiting PARP1 Polyubiquitination.Cancer science
  • Corrigendum to "Methods for isolation, detection and characterization of circulating tumor cells in epithelial ovarian carcinoma and summarized evidence of their association with survival outcome: a scoping review" [Crit. Rev. Oncol./Hematol. 227 (2026) 105614].Critical reviews in oncology/hematology
  • Megfigyeléses vizsgálatPreoperative discrimination of malignant and benign ovarian masses using cfDNA fragmentomics and serum biomarkers.Molecular biomedicine
  • ÁttekintésThe role of carbonic anhydrases IX and XII in hypoxia-driven tumor adaptation and chemoresistance: an underexplored frontier for novel therapeutic strategies in ovarian cancer.Cancer biology & therapy
  • ÁttekintésIdentification of ovarian cancer cell based on mechanical properties of regional heterogeneity of cells.Biosensors & bioelectronics
  • ÁttekintésExploring the molecular pathways of Noncoding RNAs in ovarian cancer: insights into treatment resistance.Journal of ovarian research
  • Fertility and Oncological Outcomes of Ovarian Cancer Patients Treated With Fertility Sparing Surgery.Indian journal of surgical oncology
  • PAQR5 links microvascular invasion, innate immune inflammatory amplification, and platinum resistance in ovarian cancer.Translational oncology
  • Comment on "Breast cancer prevention in patients with gBRCA-mutated ovarian cancer".Journal of cancer research and clinical oncology
  • EsetismertetésMultidisciplinary management of adult-type ovarian granulosa cell tumor in a patient with severe peripheral arterial disease and chronic limb-threatening ischemia: a case report.Journal of medical case reports
  • Practical application and exploratory prognostic assessment of the FIGO 2023 stage IA3 criteria in endometrioid endometrial cancer with concurrent ovarian tumours.International journal of clinical oncology
  • Beyond the surgeon's eye: towards a molecular definition of complete cytoreduction in advanced ovarian cancer.Gynecologic oncology
  • [Corrigendum] CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.Oncology reports
  • CT-Derived Body Composition Enhances Risk Prediction for Early Progression and Platinum Resistance in High-Grade Serous Ovarian Cancer.Cancer medicine
  • Response by Wang to "Post-PARP platinum resistance and biomarker re-evaluation in East Asian ovarian cancer cohorts".Journal of gynecologic oncology
  • Response by One et al. to "Post-PARP platinum resistance and biomarker re-evaluation in East Asian ovarian cancer cohorts".Journal of gynecologic oncology
  • ÁttekintésThe Tumor Microenvironment of Ovarian Cancer through a Spatial Topological Lens: From Immune Exclusion Mechanisms to Next-Generation Precision Interventions.Critical reviews in oncology/hematology
  • Progression on PARP versus prior PARP exposure: interpreting subsequent platinum sensitivity in ovarian cancer.Journal of gynecologic oncology
  • Correction to "Proteomic Studies That Predict Patients' Responses to High-Grade Serous Ovarian Cancer Treatments: A Systematic Review".Journal of proteome research
  • ÁttekintésTargeting histone methylation with ROS nanoparticles delivering PARPi prodrugs to amplify the stimulation of cGAS-STING for immunotherapy in ovarian cancer.Materials today. Bio
  • Combined baicalein and the neocryptolepine derivative Z2 enhance anti-ovarian cancer efficacy by inhibiting the CDK4/6-Rb signaling pathway.Toxicology and applied pharmacology
  • ÁttekintésImmunotherapy in Advanced Epithelial Ovarian Cancer: Successes and Frustrations.Oncology research
  • Hsa_Circ_0000615-Encoded 250-Amino Acid Polypeptide Suppresses Epithelial Ovarian Cancer Progression via Promoting HMGB1 Nuclear Accumulation.Oncology research
  • Expression, association with clinicopathological features and prognostic potential of FOXR2, mTOR, HIF-1α and PKM2 in high-grade serous carcinoma of the ovary.Diagnostic pathology
  • ÁttekintésMetabolic Landscape and Immune Microenvironment in Ovarian Cancer: Mechanisms of Remodelling and Therapeutic Opportunities.Immunology
  • ÁttekintésOvarian Carcinoma: Signal Pathways and Clinical Studies.MedComm
  • An interpretable machine learning model integrating 54 test indicators and age: a single-center study on precise discrimination between serous ovarian cancer and ovarian cysts.BMC medical informatics and decision making
  • RPPH1 drives ovarian cancer cells proliferation via CDK9-c-Myc axis.Journal of ovarian research
  • To interpret gypenoside-L mediated PIWI/piRNA regulatory effect on cuproptosis in ovarian cancer and the mechanism based on PANDORA-seq.Journal of natural medicines
  • Assessment of genomic instability and homologous recombination repair in ovarian cancer using the Oncomine Comprehensive Assay Plus.Oncotarget
  • CRIP1 Promotes Ovarian Cancer Progression by Mediating the KRAS-USP7 Interaction and Stabilizing KRAS.Reproductive sciences (Thousand Oaks, Calif.)
  • Complete Surgical Resection of Rare Solitary Anterior Mediastinal Metastasis From Ovarian Clear Cell Carcinoma.Respirology case reports
  • Statement of Retraction: Loss of Ras GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) inhibits the progression of ovarian cancer in coordination with ubiquitin-specific protease 10 (USP10).Bioengineered
  • Corrigendum to "Development and validation of a sensitive LC-MS/MS method for the assay of four PARP inhibitors in human plasma and its application in ovarian cancer patients" [J. Pharmaceut. Biomed. Anal. 237 (2024) 115758].Journal of pharmaceutical and biomedical analysis
  • Retraction notice to "389P Monocyte reprogramming in high-grade serous ovarian cancer and chemotherapy impact: A single-cell RNA sequencing study": [Annals of Oncology. Volume 35, Supplement 4, December 2024, Page S1549].Annals of oncology : official journal of the European Society for Medical Oncology
  • Exosomal circ_0000387 Is Associated With Ovarian Cancer Metastatic Regulation Through IGF2BP3-Related Signalling and Endothelial VWF Responses.Journal of biochemical and molecular toxicology
  • Image-guided photothermal therapy in ovarian cancer using a pH-sensitive ICG/TPZ nanoliposome to overcome thermoresistance.Colloids and surfaces. B, Biointerfaces
  • The hMOF/PCNA Axis Mitigates Cisplatin Resistance in Ovarian Cancer Cells via Modulating DNA Damage Response.Reproductive sciences (Thousand Oaks, Calif.)
  • Stromal APOL4 defines a cancer-associated fibroblast state that organizes a chemosensitive niche in ovarian cancer.Experimental & molecular medicine
  • NFE2L1 promotes cisplatin resistance by attenuating ferroptosis through SLC27A2-mediated fatty acid metabolism in ovarian cancer.Cell death and differentiation
  • ÁttekintésThe Role of miRNAs in Regulating Cellular Senescence: A Potential Strategy for Overcoming Drug Resistance in Ovarian Cancer.Frontiers in bioscience (Landmark edition)
  • Vizsgálati eredményOlaparib plus tremelimumab in women with recurrent ovarian cancer and a germline BRCA1 or BRCA2 mutation: a phase I/II study.Nature communications
  • Targeting oxidative phosphorylation with lixumistat overcomes PARP inhibitor resistance in ovarian cancer.Cell death & disease
  • Elevated human epididymis protein 4 levels in chronic kidney disease compromise the accuracy of the risk of ovarian malignancy algorithm.Experimental and therapeutic medicine
  • In situ hydrogel nanovaccine based on whole-cell tumor antigen efficiently activates adaptive immunity for the prevention and treatment of ovarian cancer.Acta pharmaceutica Sinica. B
  • Curcumin in ovarian cancer: mechanistic promise and the pharmacokinetic barrier to clinical translation.Natural product research
  • Repositioning of cis-flupentixol for the suppression of ovarian cancer cell migration and invasion through ERK5 inhibition.Molecular medicine (Cambridge, Mass.)
  • METTL3-mediated m6A modification of DNMT1 enhances ovarian cancer progression.Science advances
  • Economic evaluation alongside the PAOLA-1 /ENGOT-ov25 trial: cost of ovarian cancer and cost-effectiveness of olaparib plus bevacizumab first-line maintenance.Cost effectiveness and resource allocation : C/E
  • Chemotherapy-refractory high-grade serous ovarian carcinoma: single-cell findings, TCGA-OV transcriptomic context, and a single-case MRI-transcriptome illustration.Frontiers in genetics
  • ÁttekintésArtificial intelligence assisted genomic profiling of ovarian cancer liver metastases.Frontiers in genetics
  • Preferential toxicodynamic effects of fenbendazole in ovarian cancer and nonmalignant ovarian cell models.Drug and chemical toxicology
  • Calcified foraminal metastasis from ovarian low-grade serous carcinoma mimicking a nerve sheath tumor.Skeletal radiology
  • Application of semidefinite programming approach for detection of genomic copy number variations from peripheral blood in ovarian cancer.Frontiers in oncology
  • A modified ovarian-adnexal reporting and data system ultrasound for differentiating ovarian carcinoma: integration of the risk of malignancy algorithm into the American College of Radiology's O-RADS US framework.Frontiers in oncology
  • Patient characteristics and clinical indicators influencing oncologists' perceptions of prognosis in ovarian cancer: a discrete choice experiment.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • Poly(adenosine diphosphate-ribose) polymerase-inhibitor response evaluation in recurrent epithelial ovarian cancer using circulating tumor DNA and functional homologous recombination-deficient testing.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • Synergistic antitumor effects of combined pembrolizumab and anlotinib via EGFR inhibition and tumor microenvironment remodeling in high-grade serous ovarian cancer.Frontiers in oncology
  • Longitudinal human epididymis protein 4 kinetics in first-line treatment of advanced ovarian carcinoma: Mathematical modeling and prognostic implications.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • Prognostic value of PD-L1 expression and association with HRD in high-grade serous ovarian cancer: an ancillary analysis of the PAOLA-1/ENGOT-ov25 trial (GINECO).ESMO open
  • Integrative Multi-Model Analysis Identifies a Core Gene Signature Associated with WEE1 Inhibitor Resistance, the Resistance-Associated Tumor Microenvironment, and Therapeutic Vulnerability in Ovarian Cancer.Current cancer drug targets
  • Concentration-Based Short-Course Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at Interval Cytoreductive Surgery (iCRS) for Advanced Ovarian Cancer: Final Analysis of Overall Survival in a Phase 2 Trial.Journal of surgical oncology
  • T2-weighted MRI-based radiomics for preoperative prediction of homologous recombination deficiency status in high-grade serous ovarian carcinoma.Abdominal radiology (New York)
  • EsetismertetésPrimary ovarian insular carcinoid in an infertile woman managed with fertility preservation: a case report.BMC women's health
  • Microfluidic lipid nanoparticles co-delivering siMOB1A and paclitaxel for ovarian cancer therapy.Journal of ovarian research
  • Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS-STING-STAT3 survival axis.Clinical and translational medicine
  • MetaanalízisPrognostic factors of synchronous endometrial and ovarian cancers: a systematic review and meta-analysis of cohort studies.BMC cancer
  • CT-based adaptation of the Vizzielli laparoscopic risk-adjusted score in advanced ovarian cancer: Agreement and inter-reader reproducibility.European journal of radiology
  • Fallopian tube cytology combined with p53 and PAX-8 immunocytochemistry in diagnosing ovarian carcinoma: a prospective study.BMC cancer
  • [Uterine tumor resembling ovarian sex cord tumor: a clinicopathological and molecular analysis of ten cases].Zhonghua bing li xue za zhi = Chinese journal of pathology
  • Áttekintés[Advances and hot topics in the treatment of epithelial ovarian cancer].Zhonghua yi xue za zhi
  • Dichotomous assessments of homologous recombination deficiency are insufficient predictive biomarkers for the PARP inhibitor treatment of ovarian cancer.Clinical and translational medicine
  • Near-Infrared Light-Responsive Liposomes for Modulating Switchable CAR-T Cell Therapy.International journal of nanomedicine
  • Thoracic recurrence after complete gross resection in advanced ovarian cancer: The clinical impact of occult subdiaphragmatic lymphatic invasion.Gynecologic oncology
  • Clinical outcomes of 5-day administration of topotecan combined with bevacizumab for platinum-resistant ovarian cancer: a multicenter retrospective analysis.International journal of clinical oncology
  • Mechanical dysfunction: ovarian cancer ascites disables NK cells by suppressing CDC42-driven force generation.Frontiers in immunology
  • Boosting ovarian cancer immunotherapy via discoidin domain receptor 2 blockade and CD28 x mucin 1 bispecific antibodies.BMC medicine
  • Targeting monocyte dysregulation in ovarian cancer: insights from single-cell genomics and Mendelian randomization.Journal of ovarian research
  • ÁttekintésCell death-based treatment of ovarian cancer.Cell death & disease
  • Surgical quality and long-term outcomes in advanced ovarian cancer: a population based registry study from Hamburg, Germany 2014-2024.Archives of gynecology and obstetrics
  • Cancer stem cell marker CD44 in epithelial ovarian tumors: Association with adverse prognostic features in invasive carcinomas.Indian journal of pathology & microbiology
  • EsetismertetésA urothelial cell carcinoma in the abdominal cavity after salpingectomy for tubo-ovarian carcinoma risk reduction in a BRCA1 pathogenic variant carrier.Gynecologic oncology reports
  • Ovarian sex cord-stromal tumors are part of the BAP1-tumor predisposition syndrome: evidence from human carriers and mouse models.NPJ precision oncology
  • SLC25A39 potentiates the RXFP1/cAMP/PKA/CREB axis to drive metabolic reprogramming and tumor progression in ovarian cancer.Cell biology and toxicology
  • Regulatory mechanism of M2d tumor-associated macrophage-derived exosomal apolipoprotein E on platinum resistance in ovarian cancer.Frontiers in oncology
  • Experimental benchmarking of in silico annotations at prostate cancer risk loci and hypothesis-generating cross-cancer prioritisation of ovarian risk variants.Genomics & informatics
  • Injectable and Bio-responsive Hydrogels for On-Demand Intraperitoneal Delivery of Anti-Cancer Therapeutics in Ovarian Cancer.Acta biomaterialia
  • Ultrasonography (IOTA-ADNEX) vs magnetic resonance imaging (ADNEX MR) for diagnosing ovarian cancer in high-risk patients: a prospective study.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
  • Mechanistic ODE modelling of ovarian tumour microenvironment dynamics under hesperidin exposure.Royal Society open science
  • BRCA1 Mutation-Recognizing Tetrahedral Framework Nucleic Acid Nanoplatform Enables Coordinated PARP/WEE1 Inhibition and STING-Associated Antitumor Immunity in Ovarian Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
  • Segmentation of ovarian cancer tumors from CT images based on a two-stage neural network fusion system.Frontiers in artificial intelligence
  • TAMs-derived exosomal PD-L1 drives mitochondrial dysfunction and aberrant fatty acid oxidation via PGC-1α/PPARα axis to promote peritoneal metastasis in epithelial ovarian cancer.Journal of ovarian research
  • ESM1 drives H4K8 lactylation to promote vasculogenic mimicry and bevacizumab resistance in ovarian cancer.Cell communication and signaling : CCS
  • ÁttekintésPredictive Biomarker Tests for Ovarian Cancer: A Primer for Pathologists.Surgical pathology clinics
  • The role of laparoscopic and robotic surgery in epithelial ovarian cancer: A consensus statement of the Taiwan Association of Minimally Invasive Gynecology (TAMIG).Taiwanese journal of obstetrics & gynecology
  • ÁttekintésTargeting G2/M checkpoint vulnerability in homologous recombination-proficient tumors: lessons from ovarian cancer models.Cell cycle (Georgetown, Tex.)
  • Is the preoperative routine blood test workable to distinguish early-stage from advanced-stage ovarian cancer?Taiwanese journal of obstetrics & gynecology
  • Struma ovarii: Diagnostic pitfalls, management strategies, and clinical outcomes from a tertiary medical center.Taiwanese journal of obstetrics & gynecology
  • Optimizing treatment sequencing to the platinum-resistant ovarian cancer (PROC) patients is worthy of further identification.Taiwanese journal of obstetrics & gynecology
  • Beyond a single ratio: an adaptable deep learning approach to analyze the prognostic value of TSP distribution in ovarian cancer.The Journal of pathology
  • Expression and clinical significance of WBC, hs-CRP, and ROMA index, and tumor markers in endometriosis.BMC women's health
  • The Duffy-Null genotype and epithelial ovarian cancer survival in a cohort of Black women.Gynecologic oncology
  • Burden, Risk Factors, and Temporal Trends of Ovarian Cancer in Postmenopausal Women Aged 55 Years and Older: A Comparative Analysis in India, China, and the United States Based on the Global Burden of Disease Study 2023.International journal of women's health
  • ÁttekintésFunctional biomarkers complementing static BRCA/HRD testing for dynamic PARP inhibitor therapy in ovarian cancer: a narrative review.Frontiers in oncology
  • CD44-Targeted Antibody-Drug Conjugates Suppress Ovarian Tumor Progression and Remodels Cancer Stem Cell-Associated Molecular Programs.Advanced healthcare materials
  • Tissue Factor Expression Is Associated with Distinct Pattern of Immune-Cell Infiltration in the Ovarian Tumor Microenvironment.International journal of molecular sciences
  • Attention-based hierarchical graph autoencoder for dose-specific single-cell resistance dynamics.BMC bioinformatics
  • Exploratory Analysis of Selected MicroRNAs as Tissue-Based Candidate Biomarkers in Ovarian Cancer.International journal of molecular sciences
  • Triple-Encoding Platform for Multiplexed In Situ Profiling of Extracellular Vesicle miRNAs Enables Precision Diagnosis of Ovarian Cancer.ACS nano